Andrew Ko: Clinical Trials

1 trial sponsored by Andrew Ko, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Andrew Ko: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
FOLFIRINOX, IPI-926 - Pancreatic Cancer, Adenocarcinoma
Phase 1CompletedAndrew Ko152011-08-232017-08-08

Conditions studied

Adenocarcinoma (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Interventions

Fluorouracil (1)  ·  IPI-926 (1)  ·  Irinotecan (1)  ·  Leucovorin (1)  ·  Oxaliplatin (1)  ·  folfirinox (1)

Countries

United States (1)